Okano, M.; Oshi, M.; Butash, A.L.; Asaoka, M.; Katsuta, E.; Peng, X.; Qi, Q.; Yan, L.; Takabe, K.
Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival. Int. J. Mol. Sci. 2019, 20, 2655.
https://doi.org/10.3390/ijms20112655
AMA Style
Okano M, Oshi M, Butash AL, Asaoka M, Katsuta E, Peng X, Qi Q, Yan L, Takabe K.
Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival. International Journal of Molecular Sciences. 2019; 20(11):2655.
https://doi.org/10.3390/ijms20112655
Chicago/Turabian Style
Okano, Maiko, Masanori Oshi, Ali Linsk Butash, Mariko Asaoka, Eriko Katsuta, Xuan Peng, Qianya Qi, Li Yan, and Kazuaki Takabe.
2019. "Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival" International Journal of Molecular Sciences 20, no. 11: 2655.
https://doi.org/10.3390/ijms20112655
APA Style
Okano, M., Oshi, M., Butash, A. L., Asaoka, M., Katsuta, E., Peng, X., Qi, Q., Yan, L., & Takabe, K.
(2019). Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival. International Journal of Molecular Sciences, 20(11), 2655.
https://doi.org/10.3390/ijms20112655
